2021
- Dürr, P., Cuba, L., Schlichtig, K., Dörje, F. & Fromm, M.F. Chancen und Risiken der Therapie mit oralen Krebsmedikamenten. /Perspektive - Magazin der Frauenselbsthilfe Krebs/ *3*, 8-9 (2021)
- Madeleine Gold, Katharina Pachmann, Alexander Kiani, Rainer Schobert. Monitoring of circulating epithelial tumor cells using the Maintrac® method and its potential benefit for the treatment of patients with colorectal cancer. Molecular and Clinical Oncology 15: 201, 2021.
- Theuser AK, Hack CC, Fasching PA, Antoniadis S, Grasruck K, Wasner S, Knoll S, Sievers H, Beckmann MW, Thiel FC. Patterns and Trends of Herbal Medicine Use among Patients with Gynecologic Cancer. Geburtshilfe Frauenheilkd. 2021 Jun
- Heindl F, Fasching PA, Hein A, Hack CC, Heusinger K, Gass P, Pöschke P, Stübs FA, Schulz-Wendtland R, Hartmann A, Erber R, Beckmann MW, Meyer J, Häberle L, Jud SM, Emons J. Mammographic density and prognosis in primary breast cancer patients. Breast. 2021 Jun
- Kiani A, Roesch R, Wendtner CM, Kullmann F, Kubin T, Südhoff T, Augustin M, Schaich M, Müller-Naendrup C, Illerhaus G, Hartmann F, Hebart H, Seggewiss-Bernhardt R, Bentz M, Späth-Schwalbe E, Reimer P, Kaiser U, Kapp M, Graeven U, Chemnitz JM, Baesecke J, Lambertz H, Naumann R. Preinfection laboratory parameters may predict COVID-19 severity in tumor patients. Cancer Med. 2021 Jun
- Hatscher L, Amon L, Heger L, Dudziak D. Inflammasomes in dendritic cells: Friend or foe? Immunol Lett. 2021 Jun
- Husain B, Kirchberger MC, Erdmann M, Schüpferling S, Abolhassani AR, Fröhlich W, Berking C, Heinzerling L. Inflammatory markers in autoimmunity induced by checkpoint inhibitors. J Cancer Res Clin Oncol. 2021 Jun
- Wessely A, Steeb T, Berking C, Heppt MV. How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance. Int J Mol Sci. 2021 May
- Keck B, Borkowetz A, Poellmann J, Jansen T, Fischer M, Fuessel S, Kahlmeyer A, Wirth M, Huber J, Cavallaro A, Hammon M, Platzek I, Hartmann A, Baretton G, Kunath F, Sikic D, Taubert H, Wullich B, Erdmann K, Wach S. Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions. Cells. 2021 May
- Toussaint F, Erdmann M, Berking C, Erfurt-Berge C. Malignant Tumours Presenting as Chronic Leg or Foot Ulcers. J Clin Med. 2021 May
- Weyerer V, Strissel PL, Strick R, Sikic D, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, Breyer J, Bolenz C, Erben P, Schmitz-Draeger BJ, Wullich B, Hartmann A, Eckstein M. Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients. Cancers (Basel). 2021 May
- Agaimy A, Naroditsky I, Ben-Izhak O. Primary high-grade myoepithelial carcinoma of the lung: A study of three cases illustrating frequent SMARCB1-deficiency and review of the literature. Ann Diagn Pathol. 2021 May
- Schellerer VS, Frenger J, Merkel S, Goehl J, Kersting S, Gruetzmann R, Erdmann M, Foertsch T. Results of isolated limb perfusion for metastasized malignant melanoma. Surg Oncol. 2021 May
- Koch EAT, Wessely A, Steeb T, Berking C, Heppt MV. Safety of topical interventions for the treatment of actinic keratosis. Expert Opin Drug Saf. 2021 Apr
- Weyerer V, Strissel PL, Stöhr C, Eckstein M, Wach S, Taubert H, Brandl L, Geppert CI, Wullich B, Cynis H, Beckmann MW, Seliger B, Hartmann A, Strick R. Endogenous Retroviral-K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma. Front Oncol. 2021 Apr
- Koch EAT, Nickel FT, Heinzerling L, Schulz YK, Berking C, Erdmann M. Immune Checkpoint Inhibitor-induced Bilateral Vestibulopathy. J Immunother. 2021 Apr
- Kramer R, Zaremba A, Moreira A, Ugurel S, Johnson DB, Hassel JC, Salzmann M, Gesierich A, Weppler A, Spain L, Loquai C, Dudda M, Pföhler C, Hepner A, Long GV, Menzies AM, Carlino MS, Sachse MM, Lebbé C, Baroudjian B, Enokida T, Tahara M, Schlaak M, Hayani K, Bröckelmann PJ, Meier F, Reinhardt L, Friedlander P, Eigentler T, Kähler KC, Berking C, Zimmer L, Heinzerling L. Hematological immune related adverse events after treatment with immune checkpoint inhibitors. Eur J Cancer. 2021 Apr
- Steeb T, Follmann M, Langer T, Nothacker M, Wessely A, Garbe C, Leiter U, Berking C, Heppt MV. Online consensus conferences for the development and update of clinical practice guidelines: A survey among participants of the German S3 guideline on actinic keratosis and cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2021 Apr
- Moreira A, Lebbé C, Heinzerling L. MAPK blockade, toxicities, pathogenesis and management. Curr Opin Oncol. 2021 Mar
- Uslu U. Driving CAR T cells towards dermatologic oncology. J Dtsch Dermatol Ges. 2021 Mar
- Wessely A, Steeb T, Heppt F, Hornung A, Kaufmann MD, Koch EAT, Toussaint F, Erdmann M, Berking C, Heppt MV. A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis. Curr Oncol. 2021 Feb
- Stuebs FA, Gass P, Dietl AK, Schulmeyer CE, Adler W, Geppert C, Hartmann A, Knöll A, Beckmann MW, Koch MC. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix. Arch Gynecol Obstet. 2021 Feb
- Papaioannou NE, Salei N, Rambichler S, Ravi K, Popovic J, Küntzel V, Lehmann CHK, Fiancette R, Salvermoser J, Gajdasik DW, Mettler R, Messerer D, Carrelha J, Ohnmacht C, Haller D, Stumm R, Straub T, Jacobsen SEW, Schulz C, Withers DR, Schotta G, Dudziak D, Schraml BU. Environmental signals rather than layered ontogeny imprint the function of type 2 conventional dendritic cells in young and adult mice. Nat Commun. 2021 Jan
- Pauline Dürr, Prof. Dr. phil. nat. Frank Dörje, Prof. Dr. med. Matthias W. Beckmann, PD Dr. med. Carolin C. Hack, Prof. Dr. med. Martin F. Fromm, Katja Schlichtig. Extremer Gebrauch von Nahrungsergänzungsmitteln bei einer onkologischen Patientin. Onkologische Pharmazie. 2021 Jan
Die Versorgung von Krebspatient/-innen am Uniklinikum Erlangen erfolgt in zertifizierten bzw. begutachteten Strukturen der Deutschen Krebsgesellschaft (DKG), der Deutschen Krebshilfe (DKH) bzw. dem Bundesministerium für Bildung und Forschung (BMBF).
Im Onkologischen Zentrum (ONZ) sind die Strukturen für die klinische Versorgung zusammengefasst, im Comprehensive Cancer Center Erlangen-Europäische Metropolregion Nürnberg (CCC ER-EMN; CCC WERA) und im Nationalen Centrum für Tumorerkrankungen (NCT) die Strukturen für translationale Krebsforschung und klinische Studien.
